The CI/PI should notify both the Research Ethics Committee and the sponsor when the study ends, through its scheduled conclusion or early termination.
If you are conducting a clinical trial of an investigational medicinal product (CTIMP), please note there are statutory requirements as to how you must close your study.
|Type||Where to find|
|Key contacts||Clinical Divisions; JRCO|
|Useful links||NIHR Clinical Trials Toolkit - temp halt or early termination
NIHR Clinical Trials Toolkit - trial does not recommence
NIHR Clinical Trials Toolkit - end of trial
|NIHR benchmark||Post NIHR 70-day benchmark|
|Process map links||This activity occurs in the recruitment stage:
> Imperial College London as sponsor
> Imperial College Hospital NHS Trust as sponsor
> Commercial organisation as sponsor
> Non-commercial organisation as sponsor